Has Bryce Petersheim, PA received payments from drug or device companies?

Yes. Drug and device makers reported $6,500 in general payments to Bryce Petersheim, PA across 40 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Bryce Petersheim, PA did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Bryce Petersheim, PA come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Bryce Petersheim, PA

Surgical · Reading, PANPI 1629589981

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (45.5%), education and food and beverage — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Arthrex at 52.9% of the total. Reporting peaked in 2022 at $4,121 and has fallen 77.6% since, to $923 in 2025. Among surgical clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,500in general payments, 2019–2025

Across 40 payments — averaging $162.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Arthrex$3K
Novus Surgical Consultants$1K
Novus Surgical Solutions LLC$961
Pacira Pharmaceuticals Incorporated$904
Stryker$31
Vertex$19
plus $17 from 1 others

What the payments were for

Travel & lodging$2,95645%
Food & beverage$1,14418%
Education$2,40037%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Arthrex	13	$3,438
Novus Surgical Consultants	12	$1,129
Novus Surgical Solutions LLC	8	$961
Pacira Pharmaceuticals Incorporated	4	$904
Stryker	1	$31
Vertex	1	$19
Smith+Nephew	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Iovera$786

How this compares

$6,500 in reported general payments places this provider in the 95th percentile of 626 surgical providers in Pennsylvania.

See all surgical providers in Pennsylvania →

Medicare billing

Part B allowed, 2024

$19,513

Medicare patients

Services billed

458

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Celecoxib	24	$437
Diclofenac Sodium	20	$411
Oxycodone Hcl	66	$282
Meloxicam	30	$176
Ondansetron Hcl	42	$165
Cyclobenzaprine Hcl	16	$119

Paid to pharmacies, not to this prescriber.